Literature DB >> 22903531

Our initial experience with ALPPS technique: encouraging results.

Sofía Sala1, Victoria Ardiles, Marina Ulla, Fernando Alvarez, Juan Pekolj, Eduardo de Santibañes.   

Abstract

Surgical resection is the best option for prolonged survival in patients with primary or secondary liver tumors. A sufficient future liver remnant (FLR) volume is needed to prevent post-hepatectomy liver failure (PHLF). With the aim of increasing FLR, a new two-step technique has been recently developed. Our aim is to report our initial experience with associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) technique. Analysis was conducted of ten patients previously considered locally unresectable because of small FLR. During first surgical step liver parenchymal partition and portal vein ligation was performed. Seven days after the first procedure, once volumetric and functional studies have demonstrated an appropriate FLR volume, the resection of the deportalized hemiliver was achieved. This technique was successfully performed in all ten patients (feasibility 100 %). Six were male with mean age of 55.2 years (range 39-77). Mean preoperative FLR volume and FLR/total liver volume were 408.4 ml and 27.8 %. Mean postoperative FLR volume was 733 ml representing a mean volume increase of 325 ml or 82 % (range 31-140) (p < 0.0001). All resections were R0 (4 right hepatectomies, 5 right trisectionectomies and 1 left trisectionectomy). There were two grade A post-hepatectomy liver failures. Morbidity was 40 % and mortality 0 %. With a mean follow-up of 187 days, disease-free survival and overall survival were 80 and 100 %, respectively. ALPPS induces a great and fast FLR hypertrophy allowing R0 resections in patients otherwise considered unresectable because of small FLR volume, without severe PHLF and low mortality in experience centers. Further experience is needed to determine long-term outcomes.

Entities:  

Mesh:

Year:  2012        PMID: 22903531     DOI: 10.1007/s13304-012-0175-y

Source DB:  PubMed          Journal:  Updates Surg        ISSN: 2038-131X


  21 in total

1.  Selection of patients for resection of hepatic colorectal metastases: expert consensus statement.

Authors:  Chusilp Charnsangavej; Bryan Clary; Yuman Fong; Axel Grothey; Timothy M Pawlik; Michael A Choti
Journal:  Ann Surg Oncol       Date:  2006-09-01       Impact factor: 5.344

Review 2.  Strategies for safer liver surgery and partial liver transplantation.

Authors:  Pierre-Alain Clavien; Henrik Petrowsky; Michelle L DeOliveira; Rolf Graf
Journal:  N Engl J Med       Date:  2007-04-12       Impact factor: 91.245

3.  Standardized liver volumetry for portal vein embolization.

Authors:  Dario Ribero; Yun Shin Chun; Jean-Nicolas Vauthey
Journal:  Semin Intervent Radiol       Date:  2008-06       Impact factor: 1.513

4.  Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS).

Authors:  Nuh N Rahbari; O James Garden; Robert Padbury; Mark Brooke-Smith; Michael Crawford; Rene Adam; Moritz Koch; Masatoshi Makuuchi; Ronald P Dematteo; Christopher Christophi; Simon Banting; Val Usatoff; Masato Nagino; Guy Maddern; Thomas J Hugh; Jean-Nicolas Vauthey; Paul Greig; Myrddin Rees; Yukihiro Yokoyama; Sheung Tat Fan; Yuji Nimura; Joan Figueras; Lorenzo Capussotti; Markus W Büchler; Jürgen Weitz
Journal:  Surgery       Date:  2011-01-14       Impact factor: 3.982

5.  [New method of hepatic regeneration].

Authors:  Fernando A Alvarez; José Iniesta; José Lastiri; Marina Ulla; Fernando Bonadeo Lassalle; Eduardo de Santibañes
Journal:  Cir Esp       Date:  2011-11-14       Impact factor: 1.653

6.  Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings.

Authors:  Andreas A Schnitzbauer; Sven A Lang; Holger Goessmann; Silvio Nadalin; Janine Baumgart; Stefan A Farkas; Stefan Fichtner-Feigl; Thomas Lorf; Armin Goralcyk; Rüdiger Hörbelt; Alexander Kroemer; Martin Loss; Petra Rümmele; Marcus N Scherer; Winfried Padberg; Alfred Königsrainer; Hauke Lang; Aiman Obed; Hans J Schlitt
Journal:  Ann Surg       Date:  2012-03       Impact factor: 12.969

7.  Two-stage hepatectomy: A planned strategy to treat irresectable liver tumors.

Authors:  R Adam; A Laurent; D Azoulay; D Castaing; H Bismuth
Journal:  Ann Surg       Date:  2000-12       Impact factor: 12.969

8.  Major hepatectomy for colorectal metastases: is preoperative portal occlusion an oncological risk factor?

Authors:  L Mueller; C Hillert; L Möller; G Krupski-Berdien; X Rogiers; D C Broering
Journal:  Ann Surg Oncol       Date:  2008-05-06       Impact factor: 5.344

9.  Liver dysfunction and sepsis determine operative mortality after liver resection.

Authors:  L Capussotti; L Viganò; F Giuliante; A Ferrero; I Giovannini; G Nuzzo
Journal:  Br J Surg       Date:  2009-01       Impact factor: 6.939

10.  Postoperative liver dysfunction and future remnant liver: where is the limit? Results of a prospective study.

Authors:  Alessandro Ferrero; Luca Viganò; Roberto Polastri; Andrea Muratore; Haris Eminefendic; Daniele Regge; Lorenzo Capussotti
Journal:  World J Surg       Date:  2007-08       Impact factor: 3.352

View more
  29 in total

1.  Characterization of a porcine model for associating liver partition and portal vein ligation for a staged hepatectomy.

Authors:  Kristopher P Croome; Shennen A Mao; Jaime M Glorioso; Murli Krishna; Scott L Nyberg; David M Nagorney
Journal:  HPB (Oxford)       Date:  2015-08-02       Impact factor: 3.647

2.  Long-term results after in-situ split (ISS) liver resection.

Authors:  Sven A Lang; Martin Loss; Volker Benseler; Gabriel Glockzin; Hans J Schlitt
Journal:  Langenbecks Arch Surg       Date:  2015-02-18       Impact factor: 3.445

3.  Is the liver kinetic growth rate in ALPPS unprecedented when compared with PVE and living donor liver transplant? A multicentre analysis.

Authors:  Kristopher P Croome; Roberto Hernandez-Alejandro; Maile Parker; Julie Heimbach; Charles Rosen; David M Nagorney
Journal:  HPB (Oxford)       Date:  2015-02-28       Impact factor: 3.647

4.  How can we safely climb the ALPPS?

Authors:  Norihiro Kokudo; Junichi Shindoh
Journal:  Updates Surg       Date:  2013-09

Review 5.  Current position of ALPPS in the surgical landscape of CRLM treatment proposals.

Authors:  Marcello Donati; Gregor A Stavrou; Karl J Oldhafer
Journal:  World J Gastroenterol       Date:  2013-10-21       Impact factor: 5.742

Review 6.  Modified ALPPS procedures: more safety through less invasive surgery.

Authors:  Kuniya Tanaka
Journal:  Langenbecks Arch Surg       Date:  2017-05-10       Impact factor: 3.445

7.  Laparoscopic hepatectomy by curettage and aspiration: a report of 855 cases.

Authors:  XiuJun Cai; Lian Duan; YiFan Wang; Wenbin Jiang; Xiao Liang; Hong Yu; LiuXin Cai
Journal:  Surg Endosc       Date:  2015-10-20       Impact factor: 4.584

8.  Failure of portal venous embolization. ALPPS as salvage enabling successful resection of bilobar liver metastases.

Authors:  Soumil J Vyas; Neil Davies; Lee Grant; Charles J Imber; Dinesh Sharma; Brian R Davidson; Massimo Malago; Guiseppe Fusai
Journal:  J Gastrointest Cancer       Date:  2014-12

9.  The many faces of ALPPS: surgical indications and techniques among surgeons collaborating in the international registry.

Authors:  Suzana Buac; Erik Schadde; Andreas A Schnitzbauer; Kelly Vogt; Roberto Hernandez-Alejandro
Journal:  HPB (Oxford)       Date:  2016-03-10       Impact factor: 3.647

10.  ALPPS offers a better chance of complete resection in patients with primarily unresectable liver tumors compared with conventional-staged hepatectomies: results of a multicenter analysis.

Authors:  Erik Schadde; Victoria Ardiles; Ksenija Slankamenac; Christoph Tschuor; Gregory Sergeant; Nadja Amacker; Janine Baumgart; Kris Croome; Roberto Hernandez-Alejandro; Hauke Lang; Eduardo de Santibaňes; Pierre-Alain Clavien
Journal:  World J Surg       Date:  2014-06       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.